Visual storytelling for medical publications

Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS

@mdwrtcom
In low-risk #MDS patients use of lower hypomethylating agents’ doses was still associated with clinical efficacy, meaning more benefit and less dose-limiting toxicity
https://bit.ly/3p76XRN
#VisualAbstract #in #hematology